Parallels of infections of diabetic foot syndrome at inpatient and outpatient stages of treatment

Introduction. Long-lasting ulcerative defects in patients with diabetic foot syndrome (DFS) are prone to reinfection, persistence of primary and hospital-acquired infection, and the infectious process is often caused by multidrug-resistant organisms (MDRO).

Aim of the study: to compare the prevalence and specific characteristics of the severe diabetic foot infection pathogens during the inpatient and outpatient stages of treatment.

Materials and methods. We included 62 type 2 diabetic inpatients (group 1) with severe foot infection and 102 diabetic foot outpatients (group 2) with postoperative wounds, who had been operated on and discharged from the hospital, in to the study.

Cultures were obtained after surgery interventions immediately and on 14 days of hospitalization in group 1 of patients and in group 2 of patients with clinical signs of infection. Microbe species and resistant of pathogens to antibiotic were assessed.

Results and discussion. Severe infection connected with polymicrobe pathogens in both groups of patients. However, the prevalence of Gram-positive and Gram-negative bacilli was different. The most frequently isolated pathogens were Gram-positive bacteria in the wound samples of group 1 of patients with acute infection obtained after surgery interventions immediately. In the wound cultures of group 1 on 14 day of hospitalization and group 2 the prevalence of Gram-positive and Gram-negative bacilli was the same. It should be noted that there is still a high total frequency of isolation of non-fermenting Gram-negative bacilli among Gram-negative pathogens in complicated diabetic foot infection both at the inpatient and outpatient stages of treatment.

Conclusion. The great finding of the study is the identification of a parallel of the same prevalence of Gram-positive and Gramnegative pathogens in a prolonged infection at the inpatient and outpatient stages of treatment. The role of Enterobacterales increased with duration of infection. The prevalence of multidrug resistant Enterobacterales makes this group of microorganisms as important as Staphylococcaceae in the complicated course of the infectious process. Polyvalent microbial spectrum of pathogens significantly reduces the effectiveness of treatment.

1. Animaw W., Seyoum Y. Increasing prevalence of diabetes mellitus in a developing country and its related factors. PLoS ONE. 2017;12(11):e0187670. doi: 10.1371/journal.pone.0187670.

2. Galstyan G.R., Vikulova O.K., Isakov M.A., Zheleznyakova A.V., Serkov A.A., Egorova D.N. et al. Trends in the epidemiology of diabetic foot and lower limb amputations in russian federation according to the federal diabetes register (2013-2016). Sakharnyy diabet = Diabetes Mellitus. 2018;21(3): 170-177. (In Russ.) doi: 10.14341/DM9688.

3. Singh N., Armstrong D.G., Lipsky B.A. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217-228. doi: 10.1001/jama.293.2.217.

4. Boulton A.J.M., Armstrong D.G., Kirsner R.S., Attinger C.E., Lavery L.A., Lipsky B.A. et al. Diagnosis and management of diabetic foot complications. Arlington, Va.: American Diabetes Association; 2018. 20 p. doi: 10.2337/db20182-1.

5. Vorokhobina N.V., Zelenina T.A., Petrova T.M. Influence of the method of surgical treatment of patients with purulent-necrotic forms of diabetic foot syndrome on the recurrence rate, the risk of repeated amputations and survival. Infektsii v khirurgii = Infections in Surgery. 2009;7(4): 39-44. (In Russ.).

6. Giurato L., Meloni M., Izzo V., Uccioli L. Osteomyelitis in diabetic foot: a comprehensive overview. World J Diabetes. 2017;8(4):135-142. doi: 10.4239/wjd.v8.i4.135.

7. Zelenina T.A., Gorlinskaya E.E., Vorokhobina N.V., Zemlianoi A.B. Peculiarities of virulent pathogens in diabetic foot infections. Vestnik natsionalnogo mediko- khirurgicheskogo tsentra im. N.I. Pirogova = Bulletin of Pirogov National Medical and Surgical Center. 2012;7(2):78-80. (In Russ.) Available at: http://www.pirogov-vestnik.ru/upload/uf/50d/magazine_2012_2.pdf.

8. Tan T.-W., Shih C.-D., Concha-Moore K.C., Diri M.M., Hu B., Marrero D. et al. Correction: disparities in outcomes of patients admitted with diabetic foot infections. PLoS ONE. 2019;14(2):e0215532. doi: 10.1371/journal.pone.0215532.

9. Zelenina T.A., Vorokhobina N.V., Belevantseva N.R., Zemlianoi A.B. Factors affecting the healing of postoperative wounds in patients with purulent-necrotic forms of diabetic foot syndrome in outpatient practice. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2012;(1): 24-30. (In Russ.).

10. Ndosi M., Wright-Hughes A., Brown S., Backhouse M., Lipsky B.A., Bhogal M. et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med. 2018;35(1):78-88. doi: 10.1111/dme.13537.

11. Lipsky B.A., Senneville E., Abbas Z.G., Aragon-Sanchez J., Diggle M., Embil J.M. et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(S1):e3280. doi: 10.1002/dmrr.3280.

12. Weledji E.P., Fokam P. Treatment of the diabetic foot - to amputate or not? BMC Surg. 2014;14:83. doi: 10.1186/1471-2482-14-83.

13. Quilici M.T.V., Del Fiol F. de S., Vieira A.E.F., Toledo M.I. Risk factors for foot amputation in patients hospitalized for diabetic foot infection. J Diabetes Res. 2016:8931508. doi: 10.1155/2016/8931508.

14. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2020. Available at: http://www.cdc.gov/diabetes/data/statistics/2014statisticsreport.html.

15. Murphy-Lavoie H.M., Ramsey A., Nguyen M., Singh S. Diabetic Foot Infections. 2020. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020. Available at: https://www.ncbi.nlm.nih.gov/books/NBK441914/.

16. Fortington L.V., Geertzen J.H.B., van Netten J.J., Postema K., Rommers G.M., Dijkstra P.U. Short and long term mortality rates after a lower limb amputation. Eur J Vasc Endovasc Surg. 2013;46(1):124-131. doi: 10.1016/j.ejvs.2013.03.024.

17. Zemlianoi A.B., Zelenina T.A., Salukhov V.V., Matveev S.A. Dynamics of post-surgical wounds healing in diabetic foot outpatients. Vestnik natsionalnogo mediko- khirurgicheskogo tsentra im. N.I. Pirogova = Bulletin of Pirogov National Medical and Surgical Center. 2019;14(2):37-41. (In Russ.) Available at: http://www.pirogov-vestnik.ru/upload/uf/c6d/magazine_2019_2.pdf.

18. Zha M.-L., Cai J.-Y., Chen H.-L. A bibliometric analysis of global research production pertaining to diabetic foot ulcers in the past ten years. Foot Ankle Surg. 2019;58(2):253-259. doi: 10.1053/j.jfas.2018.08.052.

19. Ertugrul B.M., Lipsky B.A., Ture M., Sakarya S. Risk factors for infection with pseudomonas aeruginosa in diabetic foot infections. J Am Podiatr Med Assoc. 2017;107(6):483-489. doi: 10.7547/15-167.

20. Son S.T., Han S.-K., Lee T.Y., Namgoong S., Dhong E.-S. The microbiology of diabetic foot infections in Korea. J Wound Manag Res. 2017;13(1):8-12. doi: 10.22467/jwmr.2017.00108.

21. Gardner S.E., Hillis S.L., Heilmann K., Segre J.A., Grice E.A. The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes. 2013;62:923-930. doi: 10.2337/db12-0771.

22. Perim M.C., Borges J. da C., Celeste S.R., Orsolin E. de F., Mendes R.R., Mendes G.O. et al. Aerobic bacterial profile and antibiotic resistance in patients with diabetic foot infections. Rev Soc Bras Med Trop. 2015;48(5):546-554. doi: 10.1590/0037-8682-0146-2015.

23. Ramakant P., Verma A.K., Misra R., Prasad K.N., Chand G., Mishra A. et al. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia. 2011;54:58-64. doi: 10.1007/s00125-010-1893-7.

24. Bader M., Jafri A.K., Krueger T., Kumar V.F. Fusarium osteomyelitis of the foot in a patient with diabetes mellitus. Scand J Infect Dis. 2003;35(11-12):895-896. doi: 10.1080/00365540310016565.

25. Boyanova L., Mitov I. Antibiotic resistance rates in causative agents of infections in diabetic patients: rising concerns. Expert Rev Anti Infect Ther. 2013;11(4):411-420. doi: 10.1586/eri.13.19.

26. Ozer B., Kalaci A., Semerci E., Duran N., Davul S., Yanat A.N. Infections and aerobic bacterial pathogens in diabetic foot. Afr J Microbiol Res. 2010;4:2153-2160. Available at: https://www.researchgate.net/publication/281573001_Infections_and_aerobic_bacterial_pathogens_in_diabetic_foot.

27. Parsa H., Samani S. Microbiological features and risk factors in patients with diabetic foot ulcers. Wounds. 2015;27(11):308-312. Available at: https://www.woundsresearch.com/article/microbiological-features-and-risk-factors-patients-diabetic-foot-ulcers.

28. Zemlianoi A.B., Zelenina T.A., Shneider O.V. Infectious complications of diabetic foot syndrome. significance of multidrug resistant bacteria. Vestnik natsional'nogo mediko- khirurgicheskogo tsentra im. N.I. Pirogova = Bulletin of Pirogov National Medical and Surgical Center. 2018;13(2):88-91. (In Russ.) Available at: http://www.pirogov-vestnik.ru/upload/uf/7a3/magazine_2018_2.pdf.

29. Djahmi N., Messad N., Nedjai S., Moussaoui A., Mazouz D., Richardet J.-L. et al. Molecular epidemiology of Staphylococcus aureus strains isolated from inpatients with infected diabetic foot ulcers in an algerian university hospital. Clin Microbiol Infect. 2013;19(9):E398-404. doi: 10.1111/1469-0691.12199.

30. Byren I., Peters E.J.G., Hoey C., Berendt A., Lipsky B.A. Pharmacotherapy of diabetic foot osteomyelitis. Expert Opin Pharmacother. 2009;10(18):3033-3047. doi: 10.1517/14656560903397398.